{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:08:38Z","timestamp":1790964518224,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018897","name":"Lions Medical Research Foundation","doi-asserted-by":"publisher","award":["2015001964"],"award-info":[{"award-number":["2015001964"]}],"id":[{"id":"10.13039\/501100018897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Medical Research Future Fund","award":["1199984"],"award-info":[{"award-number":["1199984"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195451"],"award-info":[{"award-number":["1195451"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Donald &amp; Joan Wilson Foundation Ltd","award":["2020000323"],"award-info":[{"award-number":["2020000323"]}]},{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"publisher","award":["2018001167"],"award-info":[{"award-number":["2018001167"]}],"id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Becas Chile - ANID Postdoctoral fellowship","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancer is a leading public health issue globally, and diagnosis is often associated with poor outcomes and reduced patient survival. One of the major contributors to the fatality resultant of cancer is the development of resistance to chemotherapy, known as chemoresistance. Furthermore, there are limitations in our ability to identify patients that will respond to therapy, versus patients that will develop relapse, and display limited or no response to treatment. This often leads to patients being subjected to multiple futile treatment cycles, and results in a reduction in their quality of life. Therefore, there is an urgent clinical need to develop tools to identify patients at risk of chemoresistance, and recent literature has suggested that small extracellular vesicles, known as exosomes, may be a vital source of information. Extracellular vesicles (EV) are membrane bound vesicles, involved in cell-cell communication, through the transfer of their cargo, which includes proteins, lipids, and miRNAs. A defined exploration strategy was performed in this systematic review in order to provide a compilation of key EV miRNAs which may be predictive of chemoresistance. We searched the PubMed, Science Direct, and Scopus databases using the following keywords: Extracellular vesicles OR exosomes OR EVs AND miRNA AND Chemotherapy OR Chemoresistance OR Cancer Recurrence from 2010 to 2020. We found 31 articles that reported key EV-associated miRNAs involved in cancer recurrence related to chemoresistance. Interestingly, multiple studies of the same tumor type identified different microRNAs, and few studies identified the same ones. Specifically, miR-21, miR-222, and miR-155 displayed roles in response to chemotherapy, and were found to be common in colorectal cancer, ovarian cancer, breast cancer, and diffuse large B cell lymphoma patients (DLBCL). miR-21 and miR-222 were found to favour the development of chemoresistance, whereas miR-155 exhibited a contrasting role, depending on the type of primary tumor. Whilst high levels of miR-155 were found to correlate with chemotherapy resistance in DLBCL, it was found to be predictive of an effective response towards chemotherapy in breast cancer. Thus, further research regarding the roles of these miRNAs would be beneficial in terms of designing novel tools to counteract the progression of cancer in a not-to-distant future.<\/jats:p>","DOI":"10.3390\/cancers13184608","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T21:47:21Z","timestamp":1631656041000},"page":"4608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"given":"America","family":"Campos","sequence":"first","affiliation":[{"name":"Exosome Biology Laboratory, Center for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane and Women\u2019s Hospital, The University of Queensland, Brisbane, QLD 4029, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Sharma","sequence":"additional","affiliation":[{"name":"Exosome Biology Laboratory, Center for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane and Women\u2019s Hospital, The University of Queensland, Brisbane, QLD 4029, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[{"name":"Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Centre for Clinical Research, Building 71\/918, Royal Brisbane and Women\u2019s Hospital, Herston, QLD 4029, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-0046","authenticated-orcid":false,"given":"Carlos","family":"Salomon","sequence":"additional","affiliation":[{"name":"Exosome Biology Laboratory, Center for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane and Women\u2019s Hospital, The University of Queensland, Brisbane, QLD 4029, Australia"},{"name":"Departamento de Investigaci\u00f3n, Postgrado y Educaci\u00f3n Cont\u00ednua (DIPEC), Facultad de Ciencias de la Salud, Universidad del Alba, Santiago 8370007, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.2147\/IJN.S221383","article-title":"Exosomal Transfer of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance in NSCLC through Activating Autophagy","volume":"14","author":"Ma","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_2","first-page":"1","article-title":"Using Epigenetic Therapy to Overcome Chemotherapy Resistance","volume":"36","author":"Strauss","year":"2016","journal-title":"Anticancer. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target Recognition and Regulatory Functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1515\/cclm-2018-1048","article-title":"Extracellular vesicle-associated miRNAs in ovarian cancer\u2014Design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance","volume":"57","author":"Kuhlmann","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of Novel Genes Coding for Small Expressed RNAs","volume":"294","author":"Rauhut","year":"2001","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.31960","article-title":"Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy","volume":"144","author":"Fuji","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mir, B., and Goettsch, C. (2020). Extracellular Vesicles as Delivery Vehicles of Specific Cellular Cargo. Cells, 9.","DOI":"10.3390\/cells9071601"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New Technologies for Analysis of Extracellular Vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell\u2013derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100\u20135p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","article-title":"Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer","volume":"67","author":"Huang","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_15","first-page":"2650","article-title":"MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer","volume":"21","author":"Yuwen","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_16","first-page":"1","article-title":"MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.12659\/MSM.919219","article-title":"Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2","volume":"25","author":"Wang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Santos, P., and Almeida, F. (2020). Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance. Cells, 9.","DOI":"10.3390\/cells9061450"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Guo, Q.-R., Wang, H., Yan, Y.-D., Liu, Y., Su, C.-Y., Chen, H.-B., Yan, Y.-Y., Adhikari, R., Wu, Q., and Zhang, J.-Y. (2020). The Role of Exosomal microRNA in Cancer Drug Resistance. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00472"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1017\/S0266462321000210","article-title":"Peer review of searches for studies for health technology assessments, systematic reviews, and other evidence syntheses","volume":"37","author":"Lefebvre","year":"2021","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint\u2014Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ijc.32543","article-title":"Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma","volume":"146","author":"He","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-18-0569","article-title":"Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy","volume":"28","author":"Yuwen","year":"2018","journal-title":"Cancer Epidemiology Biomarkers Prev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/epi-2018-0123","article-title":"Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance","volume":"11","author":"Feng","year":"2019","journal-title":"Epigenomics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0981-7","article-title":"Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41598-020-60212-1","article-title":"Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prog-nosis in meta-static colorectal cancer patients","volume":"10","author":"Palomo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00280-019-03867-6","article-title":"A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer","volume":"84","author":"Jin","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-016-2308-5","article-title":"Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma","volume":"131","author":"Yang","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2019.04.034","article-title":"Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer","volume":"457","author":"Hu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/pros.22848","article-title":"miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression","volume":"74","author":"Corcoran","year":"2014","journal-title":"Prostate"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-018-0677-7","article-title":"Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K\/Akt pathway","volume":"37","author":"Fu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_32","first-page":"100","article-title":"Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer","volume":"38","author":"Kanlikilicer","year":"2018","journal-title":"EBio-Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102207","DOI":"10.1016\/j.nano.2020.102207","article-title":"miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer","volume":"28","author":"Alharbi","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.12.042","article-title":"The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells","volume":"137","author":"Pink","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Yeung","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1163-y","article-title":"Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial","volume":"16","author":"Stevic","year":"2018","journal-title":"BMC Med."},{"key":"ref_38","first-page":"1","article-title":"Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy","volume":"21","author":"Ortega","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19601","DOI":"10.18632\/oncotarget.7481","article-title":"MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes","volume":"7","author":"Zhong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.18632\/oncotarget.3520","article-title":"Endo-thelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via mi-croRNA transfer","volume":"6","author":"Bovy","year":"2015","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42339","article-title":"MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarci-noma","volume":"7","author":"Mikamori","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Svedman, F.C., Lohcharoenkal, W., Bottai, M., Brage, S.E., Sonkoly, E., Hansson, J., Pivarcsi, A., and Eriksson, H. (2018). Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206942"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0694-8","article-title":"Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_44","first-page":"1620","article-title":"Effect of rituximab combined with chemo-therapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma","volume":"23","author":"Xiao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2018.08.004","article-title":"Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma","volume":"436","author":"Zeng","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"30876","DOI":"10.18632\/oncotarget.9021","article-title":"Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/jca.28537","article-title":"Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis","volume":"10","author":"Tang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/10428194.2018.1563692","article-title":"Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory\/relapsed patients, responsive patients and patients receiving R-CHOP","volume":"60","author":"Zare","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ijlh.12560","article-title":"A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: A systematic review and meta-analysis","volume":"38","author":"Zhang","year":"2016","journal-title":"Int. J. Lab Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0536-0","article-title":"Clinical relevance of circulating cell-free microRNAs in ovarian cancer","volume":"15","author":"Nakamura","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.3892\/ol.2017.6714","article-title":"Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer","volume":"14","author":"Teng","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Staicu, C.E., Predescu, D.-V., Rusu, C.M., Radu, B.M., Cretoiu, D., Suciu, N., Cre\u021boiu, S.M., and Voinea, S.-C. (2020). Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview. Cells, 9.","DOI":"10.3390\/cells9010169"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yazici, H. (2019). Functions of miRNAs in the Development, Diagnosis, and Treatment of Ovarian Carcinoma. Current Trends in Cancer Management, IntechOpen.","DOI":"10.5772\/intechopen.85100"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1038\/onc.2008.248","article-title":"The role of PTEN signaling perturbations in cancer and in targeted therapy","volume":"27","author":"Keniry","year":"2008","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.18632\/oncotarget.401","article-title":"Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer pa-tients","volume":"2","author":"Bagnoli","year":"2011","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"32774","DOI":"10.18632\/oncotarget.5192","article-title":"miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity","volume":"6","author":"Lowry","year":"2015","journal-title":"Oncotarget"},{"key":"ref_57","first-page":"2423","article-title":"Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients","volume":"19","author":"Sasanpour","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/CMAR.S239981","article-title":"Long non-coding RNA BLACAT1 induces tamoxifen resistance in human breast cancer by regulating miR-503\/Bcl-2 axis","volume":"12","author":"Qu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1101\/gad.292318.116","article-title":"miR-424 (322)\/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy","volume":"31","author":"Nekritz","year":"2017","journal-title":"Genes Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-012-1443-3","article-title":"MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN","volume":"372","author":"Liu","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/aps.2010.48","article-title":"Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells","volume":"31","author":"Shi","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jcmm.16110","article-title":"miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2","volume":"25","author":"Vandewalle","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.molonc.2012.10.011","article-title":"The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL","volume":"7","author":"Wang","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1075-2","article-title":"Exosomal miR-21 regulates the TETs\/PTENp1\/PTEN pathway to promote hepatocellular carcinoma growth","volume":"18","author":"Cao","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_65","first-page":"1","article-title":"Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4","volume":"10","author":"Sun","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-16-1092","article-title":"Mesenchymal Stem Cell\u2013Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow","volume":"76","author":"Bliss","year":"2016","journal-title":"Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e13124","DOI":"10.1200\/JCO.2018.36.15_suppl.e13124","article-title":"Circulating exosomal microRNA profiling to depict mechanisms of chemotherapy resistance among triple negative breast cancer","volume":"36","author":"Zhao","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1007\/s13277-016-5341-2","article-title":"miR-222 induces Adriamycin resistance in breast cancer through PTEN\/Akt\/p27kip1 pathway","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19339-5","article-title":"Exosome-mediated breast cancer chemoresistance via miR-155 transfer","volume":"8","author":"Santos","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.3402\/jev.v5.31655","article-title":"Comparative analysis of EV isolation procedures for miRNAs detection in serum samples","volume":"5","author":"Andreu","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Palviainen, M., Saraswat, M., Varga, Z., Kitka, D., Neuvonen, M., Puhka, M., Joenv\u00e4\u00e4r\u00e4, S., Renkonen, R., Nieuwland, R., and Takatalo, M. (2020). Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo\u2014Implications for biomarker discovery. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236439"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2019.03.024","article-title":"Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation","volume":"177","author":"Srinivasan","year":"2019","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in Cancer: Potential and Challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clin. Epigenetics"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:35Z","timestamp":1760166155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":74,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184608"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184608","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}